Short sellers are turning aggressive on several names this week. Replimune Group tops the movers, with SI % of FF jumping to 37% — up 9.3 percentage points in just seven days. That's despite the biotech stock rallying nearly 188% over three months, a classic squeeze setup that bears appear to be fading.
EverCommerce carries the highest short score in the mid-cap universe at 93.8. Its cost to borrow spiked to 56.4% APR, with availability near zero at just 0.67% of SI. Bears are paying heavily to stay in the trade.
Doximity saw a sharp CTB surge — up 12.7 points over the past week to 13.3% APR. Short interest sits at 18.8% of FF. Shares on the medical network platform have drawn fresh bearish attention ahead of upcoming results season.
Hertz remains structurally beaten-up. SI holds at 69.2% of FF with 13.5 days to cover — a crowded trade that could snap fast if sentiment shifts.
Chewy sits at an eye-catching 94.3% of FF shorted, yet its cost to borrow is low at just 0.47%. Availability is massive at 458%, meaning bears face no squeeze pressure right now.
CoreCivic posted the second-largest weekly SI jump — up 7.9 points to 10.2% of FF — worth watching for momentum.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
